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ABSTRACT
Objective: This study was conducted to observe the dose-dependent effect of Cr (VI) on certain aspects of carbohydrate metabolism in mice with four 
different doses, viz., 5 mg/kg, 10 mg/kg, 15 mg/kg and 20 mg/kg b.w., respectively, for 30 days of exposure.
Methods: Blood glucose, glycogen content, and pyruvic acid of liver tissue were determined to evaluate the glycolytic activity. Enzymes such as 
isocitrate dehydrogenase (IDH), succinate dehydrogenase, and malate dehydrogenase (MDH) activities were measured to determine the tricarboxylic 
acid cycle function. In addition, nicotinamide adenine dinucleotide (NADH) ubiquinone C oxidoreductase activity was estimated to evaluate the 
alteration in oxidative phosphorylation pathway with dose-dependent chromium exposure. Total protein, free amino acid nitrogen, and transaminase 
enzyme activity were also measured.
Results: Chromium exposure caused marked depletion of blood glucose and liver glycogen contents in a dose-dependent manner. The activities 
of IDH, succinate dehydrogenase, and MDH were significantly altered in a dose-specific manner by chromium exposure. Relevant exhaustion of 
glycolytic substrates was noted in the form of reduced pyruvate content in hepatocytes following chromium exposure. In addition, the treatment 
caused elevation of free amino nitrogen associated with depletion of total protein content and elevated transaminase enzyme activities in hepatocytes. 
Significant alteration of mitochondrial NADH-ubiquinone C oxidoreductase activity was also noted.
Conclusion: By analyzing the observed results, it can be suggested that Cr (VI) exerts hypoglycemic and glycogenolytic effects associated with 
alteration of citric acid cycle and electron transport pathways in hepatocytes in a dose-specific manner thus resulting in serious alteration in the 
carbohydrate bioenergetics and mitochondrial energy generation in hepatic cells.
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INTRODUCTION
Chromium (Cr) is a naturally occurring transition metal; usually 
found in rocks, volcanic eruption, soil as well as plant and animals. It 
exists in various oxidation states ranging from divalent to hexavalent 
state [1]. Potassium dichromate (K2Cr2O7) and sodium chromate are 
the most important inorganic salts of hexavalent chromium (Cr [VI]) 
which have been widely used in numerous industrial processes such as 
metallurgy, tannery effluents, chrome plating, chemical industry, textile 
manufacture, wood preservation, photography and photoengraving, 
refractory and stainless steel industries and cooling systems [2,3]. As 
a result of globalization and exhaustive industrialization, heavy metal 
pollution amplified significantly throughout the world, among them the 
top seven countries which produce a larger amount of industrial effluents 
containing Cr (VI) are South Africa, India, Kazakhstan, Zimbabwe, 
Finland, Brazil, and Turkey [4]. According to the study of Banerjee et al., 
there is a trace amount of chromium present in the ground water of 
Tripura, regarding the WHO limit of chromium concentration [5].
Cr (VI) can penetrate through the cell membrane more easily than 
the other chromium compounds thus executing its potential toxic 
manifestation, and the severity of chromium toxicity depends on its 
valence state [6]. Chromate and dichromate are highly soluble in the 
water and thus readily absorbed by the gastrointestinal tract due to its 
high diffusional capacity through all types of the cell membrane [7]. 
Once inside the cell, Cr (VI) is metabolized to trivalent chromium, 
either enzymatically (via microsomal enzymes), or non-enzymatically 
(via ascorbate and glutathione) [8]. This intracellular reduction 
yields reactive intermediates, chromium (V), and chromium (IV). 
These reactive intermediates are formed along with oxygen radicals 
generated via Fenton-like and other possible reactions that occur during 
intracellular reduction [9], which also intensively trigger the massive 
production of reactive oxygen species causing oxidative damage, 
protein cross-linkage, genomic instability and apoptosis, destruction of 
cellular protein, lipid and DNA [10,11].
Main target organs of Cr (VI) toxicity are lungs, liver, intestine, oral 
mucosa, nasal mucosa, kidney and brain [11], where it causes lung cancer, 
stomatitis, gingivitis, perforation of nasal septum, skin ulceration, and 
necrosis of liver and kidney [12]. The liver is the main organ responsible 
for the metabolism, detoxification and secretory function of the organism; 
it regulates plenty of metabolic pathways of mammalian systems [13]. 
Epidemiological studies show that Cr (VI) causes hepatotoxicity in human 
and laboratory animals primarily through oxidative stress-mediated 
mechanism [14]. Tubular necrosis occurs in the kidney due to the 
exposure of Cr (VI), acute exposure causes liver and kidney damage and 
also responsible for the deterioration of organ structure [15]. A number 
of study reports show that Cr (VI) compound is also responsible 
for gastrointestinal bleeding from ulceration of intestinal mucosa, 
cardiovascular shock, kidney, and liver damage [16,17]. Sub-chronic 
exposure of Cr (VI) shows a significant decline in the levels of antioxidant 
parameters of liver and parallel increase in the lipid peroxidation [18], 
indicative of oxidative damage in tissue.
Metabolic dysfunction is one of the important mechanisms of 
chromium toxicity in various organ systems including liver. Cr (VI) 
exposure produces histiocytic cellular infiltration of hepatic and renal 
tissue owing to anomalies in carbohydrate and protein metabolism by 
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retarding rate limiting irreversible biochemical reactions of various 
crucial metabolic pathways [19]. It also leads to oliguria and proteinuria 
in mammalian system [15]. Cr (VI) is actively associated with alteration 
of normal cell to neoplastic state accompanied by extensive metabolic 
reprogramming mainly at the level of energy transducing processes 
through changes in enzymatic qualities and intracellular pools of 
their substrate and intermediator biomolecules [20]. There was least 
information about the dose-dependent toxicity study of Cr (VI) relating 
substrate and enzymological parameters of carbohydrate metabolism. 
The aim of the study is to provide a framework for the understanding 
the dose-dependent mechanism of Cr (VI) toxicity concerning 
carbohydrate metabolism in the experimental animal model.
METHODS
Materials
Potassium dichromate (K2Cr2O7 molecular weight: 294.185) 
procured from Sigma–Aldrich (India), chemicals such as sodium 
succinate, triethanolamine, sodium citrate, sucrose, diethyl ether, 
bovine serum albumin (BSA), KOH, ethanol, H2SO4, phenol, Tris-HCl, 
dichlorophenolindophenol, and ethylene diamine tetraacetic acid 
(EDTA). Were of analytical grade and purchased from Merck (India), 
SRL (India), Sigma-Aldrich (India). Biochemical kit such as glucose 
estimation kit was purchased from Coral clinical systems. Ultrapure 
water by Millipore was used throughout the experiment to avoid metal 
contamination in the preparation of reagents.
Animals
For this study, Swiss albino male mice (n=30) weighing 30-35 g were 
purchased from CPCSEA registered animal supplier. They were housed 
in polypropylene cages, acclimatized under laboratory conditions for 
1 week before starting the experiment. Animals were provided with 
standard protein diet (18% casein diet) and supplied with drinking 
water ad-libitum throughout the experiment. They were kept in 
animal house by maintaining standard air conditions of temperature 
(22°C-25°C) with 12 hrs alternating light and dark cycles.
Metallic salt selected
Chromium salts are available in various salts forms such as chlorides, 
sulfates, and nitrates and acetates which are more or less soluble 
in water. The degree of solubility depends on the hardness and 
temperature of water. As K2Cr2O7 is more soluble in deionized water, 
pure salt of K2Cr2O7 with molecular formula K2Cr2O7 and molecular 
weight 294.18 was used in this study.
Experimental design
Initially, the animals were divided into two groups of equal average body 
weight, the control, and Cr (VI)-treated groups. Further, the animals of 
the Cr (VI)-treated group were subdivided into four separate groups for 
dose-dependent study. The animals of each group were six in number 
(n=6), and they were subjected to the following treatment protocol.
Control group
Animals received normal saline (0.9% NaCl) orally.
Chromium-treated groups
 Group I - The animals of this group were treated with hexavalent 
chromium (as K2Cr2O7) at a dose of 5 mg/kg b.w./day orally for 
30 days).
 Group II - The animals were treated with chromium at a dose of 
10 mg/kg b.w./day orally for 30 days.
 Group III - The animals of this group received chromium at a dose 
of15 mg/kg b.w./day orally for 30 days.
 Group IV - Treated with potassium dichromate at a dose of 
20 mg/kg b.w./day orally for 30 days.
Animal sacrifice
After the treatment was over, all the animals were sacrificed by cervical 
dislocation following the guideline of the Institutional Animal Ethical 
Committee.
Collection of blood
Blood was collected from the hepatic vein of all experimental animals 
and refrigerated at -20˚C until biochemical analyses were performed.
Separation of tissue
After sacrifice, liver tissue was collected from all the animals, washed 
in ice-cold saline (0.9%), blotted dry, weighed and kept at −20°C for 
biochemical analyses. Liver from control and one of the treated groups 
(Group II) was taken and fixed in 10% (pH 7.4) neutral buffered 
formalin solution and processed for histopathological evaluation.
Preparation of tissue homogenate
The tissue homogenate was prepared in suitable buffer solution 
(e.g., 0.1 M phosphate buffer, pH 7.4, 0.25 M sucrose solution) as required 
for different analytical methods using Potter Elvenjem glass homogenizer.
Isolation of mitochondria from liver tissue
The mitochondria of liver tissue was isolated according to the method 
of Dutta et al. [21]. A portion of the liver tissue was cleaned and cut 
into small pieces. 500 mg of the tissue were placed separately in 
10 ml of sucrose buffer (0.25 [M] sucrose, 0.001 [M] EDTA, 0.05 
[M] Tris-HCl [pH 7.8]) at 25°C for 5 minutes. The tissue was then 
homogenized separately in cold for 1 minute at low speed using a Potter 
Elvenjem glass homogenizer (Belco Glass Inc., Vineland, NJ, USA). The 
homogenate was centrifuged at 1500 rpm for 10 minutes at 4°C. This 
supernatant was centrifuged at 4000 rpm for 5 minutes at 4°C. The 
supernatant, thus obtained, was further centrifuged at 14,000 rpm for 
20 minutes at 4°C. The final supernatant was discarded, and the pellet 
was re-suspended in sucrose buffer and stored at −20°C until further 
analysis. However, most of the enzymatic assays were carried out with 
freshly prepared mitochondrial suspension.
Morphophysiological analyses
Body weight and organosomatic index
The body weight of each animal of each group was taken onward the 
commencement day of treatment and also noted periodically until 
sacrifice to observe the changes in body weight in different groups. 
The organ weight (whole liver) of respective group of animals was 
also recorded after sacrifice of the animals. From these, organosomatic 
index (OSI) of the liver was calculated [22].
Organo somatic index
Weight of theorgan(g)






To determine the glycogen content of liver tissue the method of 
Montgomery [23] was used. In brief, approximately 300 mg of liver tissue 
was mixed with 1 ml of 30% KOH solution and placed in a boiling water 
bath for 15-20 minutes and then cooled at room temperature. It was 
then added with ethanol, again heated and cooled at room temperature. 
The mixture was centrifuged at 3000 rpm for 10 minutes, and the 
supernatant was discarded. Ethanol washing was repeated twice, and 
the resultant precipitate was taken for the estimation of glycogen. The 
glycogen content was expressed in terms of mg/g of liver tissue.
Blood glucose level
Glucose contents of blood samples were measured by GOD-POD kit 
method following the method of Barham and Trinder [24]. Briefly, 
1 ml of the working reagent was mixed with 10 µl of the sample and 
incubated for 10-15 minutes at 37°C. Similarly, a blank and a standard 
were prepared using 10 µl of distilled water and a standard solution, 
respectively. After the incubation, the absorbance was taken at 500 nm. 
The level of blood glucose was expressed as mg/dl.
Liver pyruvic acid content
The liver pyruvic acid content was estimated according to the protocol 
of Segal et al. [25]. Briefly, 10% tissue homogenate was centrifuged at 
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3000 rpm for 10 minutes, with 5% tricarboxylic acid cycle (TCA). The 
resultant supernatant was mixed with 1 ml distilled water and 0.5 ml 
2, 4 DNPH and shaken it for 3 minutes. Then, toluene was added and 
mixed vigorously by hand shaking for few min. After that added, 2 ml of 
sodium carbonate and sodium hydroxide solution each to measure the 
optical density at 420 nm. The observed result was expressed as mg%.
Determination of the activity of TCA cycle
Isocitrate dehydrogenase (IDH) activity
Mitochondrial IDH activity was measured according to the method of 
King [26]. To 0.1 ml of Tris-HCl, 0.2 ml of trisodium isocitrate, 0.3 ml 
of manganese chloride, 0.2 ml of mitochondrial suspension and 0.2 ml 
of NADP (0.2 ml of saline for control) were added. After incubation, 
0.001 M of DNPH was added followed by 0.005 M of EDTA and then 0.4 N 
NaOH was added, OD was taken at 420 nm in an UV spectrophotometer. 
The enzyme activity was expressed as unit/min/µg of protein.
Succinate dehydrogenase (SDH) activity
The SDH activity was measured spectrophotometrically by following 
the reduction of K3Fe(CN)6 at 420 nm according to the method of Dutta 
et al. [21]. 1 ml of the assay mixture contained 50 mM phosphate buffer 
(pH 7.4), 2% (w/v) BSA, 4 mM succinate, 2.5 mM K3Fe(CN)6 and a 
suitable aliquot of the enzyme. The enzyme activity was expressed as 
units/min/mg of tissue protein.
Assay of malate dehydrogenase (MDH)
This enzyme activity was determined by the method of Mehler 
et al. [28] using an assay mixture containing potassium phosphate 
buffer, 0.0076 M oxaloacetic acid and 0.005 M nicotinamide adenine 
dinucleotide (NADH) at pH 7.4. The reduction of NADH was measured 
at 340 nm for 5 min with 10 seconds interval and expressed the activity 
as mmole of NADH oxidized/min/mg of protein.
Determination of the activity of electron transport chain
NADH: Ubiquinone C oxidoreductase activity
The activity of NADH: Ubiquinone C oxidoreductase (NADH dehydrogenase) 
was measured by the method of Minakami et al. [29]. The reaction mixture 
contained 1 ml phosphate buffer, 0.1 ml of potassium ferricyanide and 
0.2 ml mitochondrial suspension in a total reaction volume of 3 ml with 
distilled water. Freshly prepared (0.1%) NADH solution was added just 
before the addition of the enzyme except the control set. The change in the 
OD was measured at 420 nm for 3 minutes and the enzyme activity was 
expressed as mmole of NADH oxidized/min/mg of protein.
Determination of total protein content and gluconeogenic 
substances
Tissue protein content
The protein content was estimated according to the method of Lowry 
et al. [30]. To 0.1 ml of tissue homogenate, 0.9 ml of water and 4.5 ml of 
alkaline copper reagent were added and kept at room temperature for 
10 min. To this, 0.5 ml of Folin’s reagent (1:2) was added and the blue 
color developed was read after 20 minutes at 640 nm. Protein content 
was expressed as mg%.
Free amino acid nitrogen content
The 5% tissue homogenate (in 0.1 M PB, pH 7.4) was first dissolved in 
0.67 (N) H2SO4 and 10% Na-tungstate to precipitate proteins and then 
centrifuged to get the protein-free extract. The resultant supernatant was 
treated with cyanide acetate buffer and 3% ninhydrin solution as per the 
protocol proposed by Rosen [31]. After that, the solution was heated at 
100°C in a water bath for 5 minutes and immediately after cooling added 
with isopropanol to develop a violet color. Optical density of that colored 
solution was measured in a spectrophotometer at 570 nm.
Glutamate pyruvate transaminase (GPT) and glutamate-
oxaloacetate transaminase (GOT) activities
The transaminase enzyme activities in the studied tissue were 
determined following the method of Reitman and Frankel [32]. For this 
assay, the standard kit (Coral clinical systems, Goa, India) was used to 
measure photometrically the color intensity of the reaction mixture. In 
general, the color was formed due to the chemical of reaction of alanine 
with α-ketoglutarate to form pyruvate in the case of GPT, whereas the 
aspartate was used to react with α-ketoglutarateto originate pyruvate 
in the case of GOT. After this enzymatic reaction, all the tubes were 
allowed to incubate at 37°C for a specific period of time and absorption 
noted at 505 nm. The enzyme activity was expressed in terms of units/
mg of tissue.
Histological study
For histopathology of the liver of both control and Cr (VI) treated mice 
were preserved in 10% neutral buffered formalin solution for 24 hrs. 
After proper dehydration in graded alcohol, clearing, impregnation 
and embedding, tissue sections were prepared by rotary microtome. 
These sections obtained from the respective groups were stained 
using hematoxylin-eosin and examined under both low and power of 
microscope and photomicrographs were taken using ×20 objective.
Statistical analysis of data
The statistical analyses were performed by Student’s t-test and values 
were expressed as means±standard error of mean. The minimum 
criterion for statistical significance was set at p<0.05.
RESULTS
Changes in the body weight following sub-acute chromium exposure 
have been represented in Table 1 which reveals that chromium 
treatment at the present dose and duration has no significant effect on 
the body weight changes of experimental mice.
It is further shown in Table 1 at chromium intoxication affects the 
organo-somatic index of mice liver. The liver-somatic index (LSI) 
was increased gradually in all the treated groups of mice in a dose-
dependent manner. The changes were observed as follows: In Group I, 
it was 7.51% (p<0.01), in Group II, 10.65% (p>0.05), in Group III, 9.93% 
(p<0.05) and in Group IV 21.54% (p<0.01).
Table 2 demonstrates that hexavalent chromium exposure significantly 
altered the blood glucose level. The percentage of decrease was 
highest in Group II (58.27%; p<0.01) and less in Group IV (10.73%, 
p<0.05); although the glucose content decreased in Group I and III, the 
percentage changes were observed as 18.46% (p<0.05) and 52.37% 
(p<0.01), respectively.
It is revealed from Table 2 that the glycogen content of liver of 
chromium-treated mice significantly decreased gradually. The 
percentage of decreased glycogen content observed was 3.7% 
(p<0.05), 20.98% (p<0.05), 42.58% (p<0.05) and 70.06% (p<0.05) in 
Groups I, II, III and IV, respectively.
It is revealed from Table 2 at Cr (VI) exposure results in gradual decrease 
in pyruvic acid content of hepatic tissue in a dose-specific manner. 
The decreasing pattern was as follows: 42.32% (p<0.05), 48.12% 





weight (g) after 
30 days
LSI liver weight×100/body 
weight (g)
Control 35.75±3.07 4.13±0.23
Group I 39.03±2.65 4.44±0.29**
Group II 35.29±4.31 4.57±0.38*
Group III 36.24±4.97 4.54±0.29*
Group IV 37.11±0.88 5.02±0.55**
Values are means±SEM. *p<0.05 and **p<0.01 are considered statistically 
significant; n: Number of animals, LSI: Liver-somatic index, SEM: Standard error 
of mean
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(p<0.05), 61.05% (p<0.05) and 62.27% (p<0.01) correspondingly in 
Groups I, II, III and IV due to Cr (VI) toxicity.
Fig. 1 represents that the IDH activity in mice liver increased in 
Groups II, III and IV where gradually higher doses of chromium were 
administered. The increase was found to be 15.48% (p<0.01), 33.58% 
(p<0.01) and 48.88% (p<0.05), respectively; but in Group I the IDH 
activity was slightly decreased by 26.49% (p<0.05) at the lowest dose 
of chromium exposure.
The result presented in Fig. 2 reveals that chromium treatment at the 
present doses and duration significantly decreased the SDH activity 
in first two groups (Groups I and II). In those groups, the decrease 
was noted as 9.33% (p<0.05) and 20% (p<0.001), respectively. On 
the other hand, increased activity of the enzyme was observed in 
Groups III and IV, indicating stimulating effect of hexavalent chromium 
by 61.33% (p<0.01) and 91.33% (p<0.01) at higher doses.
Fig. 3 indicates that the MDH activity in mice liver was significantly 
increased in Groups I and II by 76.07% (p<0.001) and 104.29% 
(p<0.01), respectively, whereas in next two successive doses of 
chromium exposure the increased activity of MDH was noted as 20.25% 
(p<0.05) and 12.88% (p>0.01), respectively, in Groups III and IV as 
compared to control.
As represented in Fig. 4, chromium intoxication significantly decreased 
NADH-ubiquinone C oxidoreductase activity in all the groups of mice 
in comparison to the control value. The percentage changes were 
observed as 87.24% (p<0.01), 79.95% (p<0.01), 56.15% (p<0.001) and 
72.44% (p<0.01) in Groups I, II, III, IV, respectively.
Table 3 represents that the liver protein content was decreased in a 
dose-dependent manner significantly by 8.06% (p<0.001), 24.78% 
(p<0.001), 35.98% (p<0.05) and 55.45% (p<0.01), respectively, at 
gradually increasing doses of exposure.
The free amino nitrogen level was elevated with increased doses of 
chromium by 345.78% (p<0.05), 590.9% (p<0.05), 645.46% (p<0.01) 
and 6381.82% (p<0.05) in Groups I, II, III, IV, respectively (Table 3).
The GPT activity in liver was increased by 68.44% (p<0.01), 96.56% 
(p<0.05), 133.68% (p<0.05) and 176.46% (p<0.01) from Group I to 
Group IV. The GOT activity was also elevated in chromium exposed mice 
liver by 19.08% (p<0.05), 59.28% (p<0.01), 109.12% (p<0.01) and 
144.67% (p<0.05) in Groups I, II, III and IV, consecutively as compared 
to the control (Table 3).
In Fig. 5, it further reveals the hepatotoxic effect of Cr (VI) exposure 
where it points out significant alteration in normal pattern of hepatic 
radiation and hypercellularity near to the central vain. It also shows the 
hepatic steatosis and excessive microvesicular inflammation in the liver 
tissue.
DISCUSSION
Environmental pollutants are known to alter the physiological and 
biochemical status of the animals by inducing changes in the activity 
of several enzymes and metabolites. Heavy metals are non-degradable 
Table 2: Changes in blood glucose, liver pyruvate, and glycogen contents due to different doses of hexavalent chromium treatment
Groups of animals (n=6) Blood glucose (mg/dl) Pyruvic acid content in hepatic tissue (mg%) Glycogen content (mg/gm of liver 
tissue)
Control 177.04±3.07 156.98±3.42 101.38±2.23
Group I 144.35±2.65** 91.04±2.84* 78.46±1.29**
Group II 72.64±2.31** 79.56±1.26** 72.68±1.38**
Group III 84.50±1.97** 61.48±1.84** 68.42±0.86*
Group IV 154.42±2.88** 59.56±1.64* 28.97±0.55**
Values are means±SEM. *p<0.05 and **p<0.01 are considered statistically significant; n: Number of animals, SEM: Standard error of mean
Fig. 1: Dose-dependent changes in the isocitrate dehydrogenase 
enzyme activity in mice liver after Cr (VI) exposure. Values 
are means±standard error of mean. *p<0.05 and **p<0.01 are 
considered as statistically significant. X-axis represents different 
doses of chromium and Y-axis represents the unit
Fig. 2: Dose-dependent effects of chromium on succinate 
dehydrogenase enzyme activity in hepatocytes of mice. Values 
are means±standard error of mean. *p<0.05, **p<0.01 are 
considered statistically significant and ***p<0.001 indicates 
very high significance of difference between control and treated 
groups. X-axis represents different doses of chromium and Y-axis 
represents the unit
Fig. 3: Dose-dependent alteration of malate dehydrogenase 
enzyme activity in chromium exposed mice hepatocyte. Values 
are means±standard error of mean. *p<0.05, **p<0.01 are 
considered statistically significant and ***p<0.001 indicates 
very high significance of difference between control and treated 
groups. X-axis represents different doses of chromium and Y-axis 
represents the unit
pollutants in environment which easily enter into the organisms 
through food and respiratory surfaces, affecting their physiological 
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functions [16]. Most of the living organisms derive energy by the 
metabolic breakdown of carbohydrates. The chief carbohydrate in the 
tissue is glycogen, while glucose is utilizable sugar found in the tissue and 
body fluids. Glycogen which is stored reversibly converted into glucose 
under the influence of hormone-mediated enzyme activities [33]. 
Moreover, the equilibrium between gluconeogenesis and glycogenolysis 
tends to maintain the blood sugar at a steady state. The oxidation of 
glucose is mediated by catabolic pathways, viz., glycolysis, Kreb’s cycle, 
electron transport system and hexose monophosphate shunt which 
constitute the major segments of carbohydrate metabolism [34]. This 
study explores some new information regarding the differential effect 
of hexavalent chromium in a dose-dependent manner on certain 
aspects of glucose metabolism in mice model.
This study shows that the LSI significantly increased in all groups of 
chromium exposed mice. Although the body weights of the treated 
animals were not significantly altered, significant change in liver weight 
in respect to the body weight was noted after chromium intoxication 
at the present dose and duration. Alteration in the LSI reflects hostile 
effect to hepatocellular metabolism and energy storage mechanism 
in freshwater fish model [35]. These findings are also supported by 
the fact that hexavalent chromium could induce thickening of blood 
vessel and perivascular inflammation in various vital organs of the 
experimental animal [36,37]. Hence, it is assumed that due to some 
inflammatory changes in the intra-hepatocellular spaces, the LSI 
increased significantly following exposure to chromium.
It is revealed from this study that the blood glucose level significantly 
decreased in all the chromium exposed animals. The maximum 
depletion of blood glucose level was found in Group II (10 mg/kg), 
which may be due to defective reabsorption of glucose or enhanced 
excretion of glucose leading to hypoglycemia in chromium exposed 
mice. Earlier studies on fish model revealed hypoglycemic effect of 
chromium at a low dose of exposure for 2 months [38]. Experimental 
studies demonstrated that renal tubular damage and glycosuria 
are accompanied with the alteration in the activity of different 
enzymes and proteinuria, which could be the associated factors of 
hypoglycemia [14]. The decreased glucose may be due to nephritic 
tissue abnormality or may result from increased rate of glycolysis 
and excessive metabolism in various vital organs including liver to 
make up the high energy demand for attenuating the toxic effect of 
chromium. This is supported by the fact that heavy metal toxicity has 
the retrogressive effect on compelling metabolic pathways in various 
experimental animals [39,40]. It is further noted that the glycogen 
depletion is maximum in the high dose exposed group that might be a 
contributory factor for replenishment of the loss of blood glucose level 
following exposure to chromium.
Moreover, glycogen is the storage carbohydrate and it occurs mainly 
in hepatic and muscular tissue and is reversibly converted to blood 
glucose which serves to maintain blood glucose level when the supply 
of carbohydrates from the intestinal absorption is inadequate [41]. 
Metabolic breakdown of glycogen assumes considerable importance 
in studies involving liver and muscle glycogen levels. The amount of 
glycogen significantly decreased in the present study in all chromium 
treated groups as compared with the control value. The decreasing 
value of glycogen is lower in the low dose exposure group and that 
is exponentially higher in the increasing doses of toxicant exposure, 
indicating a dose-dependent decrease in glycogen content in that 
tissue exposed to chromium. Decrease in glycogen level may be caused 
by the decrease in its synthetic rate or may be utilized by the animal 
for its metabolic activities [42]. Maintenance of glycogen reserves is 
one of the important features of the normal metabolism. Alterations 
in liver glycogen under situations of stress have been reported, and 
a significant depletion in tissue glycogen is said to reflect a state 
of strenuous activity on the part of the experimental animal [43]. 
A consistent decrease in tissue glycogen reserves observed in this 
study also suggests enhanced glycogenolysis. Further, the decline 
in glycogen might be partly due to its utilization in the formation of 
glycoproteins and glycolipids, which are essential constituents of 
various cells and other membranes [43]. It is further suggested that 
the mobilization of carbohydrates for the energy purpose may be a 
compensatory measure to counter the toxic effects of heavy metals 
such as chromium and others [44].
Fig. 4: Variation in nicotinamide adenine dinucleotide 
ubiquinone C oxidoreductase activity following Cr (VI) treatment 
in liver tissue of experimental mice. Values are means±standard 
error of mean. **p<0.01 is considered statistically significant and 
***p<0.001 is considered as statistically highly significant. X-axis 
represents different doses of chromium and Y-axis represents 
the unit
Table 3: Changes in total protein content, GPT and GOT activities and free amino nitrogen content in hepatic tissue following chromium 
exposure
Groups of animals (n=6) Total protein content in 
hepatic tissue (mg%)
GPT activity unit/mg of 
tissue
GOT activity unit/mg of 
tissue
Free amino nitrogen mg%
Control 82.92±2.24 135.26±1.78 221.42±2.01 0.11±0.23
Group I 76.24±1.32*** 227.82±0.29** 263.68±4.29* 0.49±0.09*
Group II 62.38±1.54*** 265.88±1.92* 352.72±5.1* 0.76±0.05*
Group III 53.08±2.29* 316.08±3.29* 463.02±7.29** 0.82±0.19**
Group IV 38.94±1.95* 373.94±5.55** 541.75±7.55* 0.86±0.55*
Values are means±SEM. *p<0.05, **p<0.01 and ***p<0.001 are considered statistically significant; n: Number of animals, SEM: Standard error of mean, GPT: Glutamate 
pyruvate transaminase, GOT: Glutamate-oxaloacetate transaminase
Fig. 5: Altered histopathological characters of liver tissue 
after chromium exposure. (a) Control: (A) regular portal 
vain (B) standard hepatocellular radiation, (b) Cr-treated: 
(A1) inflamed portal vein with hypercellularity in adjacent area 
(B1) disintegrated normal radiating pattern of hepatocytes 
(C) steatohepatitis with steatosis with number of macrovesicular 
inflammatory foci (hematoxylin-eosin stain, ×20 magnification)
ba
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Pyruvate is the final product of glycolytic reaction and acts as an 
important intermediate for the citric acid cycle; hence, it is crucial for 
energy generation [20]. In this study, pyruvate content of hepatocytes 
was prominently declined with increasing dose of the chromium in 
the experimental mice. According to Xiao et al. [45] Cr (VI) exerts, its 
deleterious and negative effects on the bioenergetics of the hepatic 
tissue by altering the molecular status of metabolites and also by 
triggering ample amount of oxidative stress molecules. Cr (VI) inside the 
cell gets reduced to Cr (III) by Fenton reaction and this reduced product 
deport itself as competitive inhibitors for several ATP-dependent 
kinases those are actively imparted in the glycolytic reactions in 
cellular processes [46]. This might be an important causative factor 
for Cr (VI) mediated unfavorable effect on hepatocellular glycolysis 
and subsequently decrease in pyruvate production in the liver tissue of 
Cr (VI) exposed mice.
The result of this study shows that NADH dehydrogenase activity 
significantly decreased in all groups of animal owing to the highest 
degree of toxicity in 5 mg/kg b.w. Exposure group and less degree of 
toxicity was found in 15 mg/kg b.w. Cr (VI) exposure group. NADH 
dehydrogenase is the entry enzyme of cellular respiration in the 
mitochondria where it transfers electron from NADH to ubiquinone 
in the process of electron transport chain. As a result of the reaction, 
this enzyme translocates four protons (H+) molecules across the inner 
membrane of mitochondria per molecule of NADH generating an 
electrochemical potential to construct high energy ATP. The decreasing 
activity of NADH dehydrogenase, as observed in the present study may 
be due to the toxic stress imposed by Cr (VI) in the mitochondria of the 
hepatic tissue. The less availability of substrate like NADH is supposed 
to be involved in chromium-induced decreased NADH dehydrogenase 
enzyme activity. It was reported that K2Cr2O7 triggers structural and 
enzymatic alterations in rat kidney by single exposure [47]. Such kind of 
enzymatic alteration is also observed in chromium exposed mice in this 
study. These findings are further supported by the earlier studies where 
mitochondrial and cytosolic enzymes for carbohydrate biopolymers 
undergo alteration and disruption on exposure to Cr (VI) [48]. The 
activity of this enzyme differs in a dose-specific manner which may 
be correlated with relative availability of the substrates such as NADH 
required for the optimal activity of the enzyme.
IDH is an important enzyme of the mitochondrial matrix and plays 
a crucial role in citric acid cycle. The enzyme involves in oxidative 
decarboxylation reaction and produces α-ketoglutarate and NADH 
which are the two important biomolecules for cellular energy. However, 
the activity of IDH depends on some important co-substrate like NADP 
and cofactor such as Mg+2 for the final execution of its function. IDH 
catalyses the irreversible reaction of TCA, allosterically positively 
regulated by the ADP and inhibited by the ATP and NADH. This study 
shows a significant decrease in the enzyme activity after exposure 
to chromium at 5 mg/kg dose, followed by a gradual increase in the 
enzyme activity in successive doses, giving a hyperbolic pattern. These 
indicate a clear dose-specific effect of Cr (VI) on this enzyme activity. It 
is postulated that chromium being a potent oxidative stress generator 
in various organs may induce overproduction of free radicals that might 
affect the enzymes of the citric acid cycle and tend to decrease their 
general biological activities [49]. It is suggested that decreased IDH 
activity might be a causative factor for decreased production of NADH 
and thus may influence the activity of NADH dehydrogenase.
The present study further demonstrates that the succinate 
dehydrogenase enzyme activity of liver tissue significantly increased 
in the higher doses of chromium exposure, whereas at low doses of 
exposure there was no significant effect of chromium on this enzyme 
activity. Succinate dehydrogenase is the common enzymological 
parameter for both citric acid cycle and electron transport chain. In 
electron transport chain, it acts as the mitochondrial complex II and 
oxidizes succinate to fumarate, and at the same time, it also reduces 
the ubiquinone thus completing its programed function in oxidative 
phosphorylation pathway as well as citric acid cycle. Hypoglycemic 
condition enhances the beta oxidation rate thus resulting in the 
production of abundant number ketone bodies which in turn triggers 
enhanced energy coupling reaction for ATP production in mitochondria 
through improving and maintaining reduced ubiquinone pool in the 
tissue [50]. Increased activity of succinate dehydrogenase was observed 
in hypoglycemia threatened cardiomyocytes [50]. Enhanced glucose 
and protein excretion with decreased activities of alkaline phosphatase, 
glucose-6-phosphatase and succinate dehydrogenase in nephritic 
tissue were observed in subchronic chromium intoxication [49].
Changes in MDH activity reveal that chromium exposure at the present 
dose and duration caused gradual increase in the enzyme activity up 
to 10 mg/kg dose of exposure, followed by declining activity of the 
enzyme at higher doses of chromium treatment. The MDHcatalyses the 
NAD/NADH-dependent interconversion of the substrates like malate 
and oxaloacetate. This reaction plays a key part in the malate/aspartate 
shuttle across the mitochondrial membrane, and in the TCA within the 
mitochondrial matrix. Reports are available in support of alteration and 
disruption of mitochondrial and cytosolic enzymes for carbohydrate 
biopolymers on exposure to Cr (VI) [48]. Enhanced of MDH activity 
at low doses of chromium exposure indicates stimulating effect of 
chromium on enzyme activity to facilitate the production of energy via 
TCA cycle in hypoglycaemic-stressed animals. On the other hand, an 
adaptive mechanism was gradually developed to maintain equilibrium 
in energy production as a result of high dosage of chromium exposure.
A typical physicochemical commotion of the SDH and NADH 
dehydrogenase, key parameters of electron transport chain produces 
an unfavorable condition in the mitochondrial inner environment 
which may hamper the final execution of energy production in terms 
of ATP. It is reported that heavy metal can induce the proton leakage 
from ETC which also contribute for the stress radical generation which 
in turn can hamper the mitochondrial enzyme system concerning the 
energy production [51]. In the present study, chromium exposure 
significantly decreased the activity of NADH dehydrogenase, which 
was mostly affected in the lowest dose of exposure indicating that 
the mitochondrial electron transport chain is sensitive to low dose 
of chromium. Mitochondrial complex I is one of the main sites where 
the premature electron leakage causes the production of superoxide 
in the presence of oxygen. Hence, the inhibited NADH dehydrogenase 
activity due to chromium exposure may enhance the accumulation of 
free electrons and consequently superoxide anions producing oxidative 
stress.
Elevated transaminases activity recognizes hepatic toxicity with 
chromium administration [52]. It is well established that transaminase 
activity enhanced with ill health of hepatocytes and also increases 
protein degradation in the specific tissue [51]. Transaminases are 
also responsible as supplier of gluconeogenic intermediates and other 
biochemical pathways [54]. Tissue protein degradation and increased 
GPT and GPT activity further promote vulnerable situation inside the 
hepatocytes leading to the severe cellular damage by the Cr (VI). Free 
amino nitrogen content was prominently increased in the present 
study and reveals that Cr (VI) significantly increases the protein 
degradation and enriches amino acid pool for further utilization in 
energy production, cellular reparation and may be due to maintain the 
homeostatic condition between the important metabolic pathways in 
the liver during toxic situation [55].
Other than biochemical changes chromium exposure at the dose of 
10 mg/kg body for the present duration caused marked morphological 
changes in liver tissue as evidenced by the formation of steatosis 
and altered radiating pattern of hepatic cells. These findings thus 
substantiate hepatic tissue damage-promoting metabolic dysfunctions.
CONCLUSION
In a nutshell, the successive study depicts that Cr (VI) agitates main 
bioenergetics of carbohydrate metabolism by conflicting with normal 
physicochemical attributes of several substrates and enzymes of 
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citric acid cycle as well as electron transport chain. Hypoglycemia and 
retardation of glycolysis are evidenced in chromium-induced toxic 
manifestation. It also interferes with liver glycogen content in a great 
extent thus may serve as a compensatory mechanism to hypoglycemic 
situation. The study reveals that the citric acid cycle enzyme activities 
were abruptly changed with differential doses of Cr (VI) exposure and 
the activity of mitochondrial complex I was also seriously hampered 
with this heavy metal. Cr (VI), being a free radical generator may acquire 
capability of thickening the blood vessel, perivascular inflammation 
leading to alteration of LSI. Histopathological alteration showing 
steatosis in the liver also supports the changes in liver weight. Thus, 
it may be concluded that hexavalent chromium having the quality to 
disturb hepatic energy metabolism alters substrate and enzymological 
parameters of the glycolysis, citric acid cycle, and mitochondrial 
electron transport chain in a dose-specific manner.
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